Is Energy Transfer a Good Dividend Stock to Buy Now?
Energy Transfer (NYSE:ET) offers an impressive yield, to say the…
Sell
23
AKTX Quote, Financials, Valuation and Earnings
Last price:
$1.04
Seasonality move
:
-6.68%
Day range:
$1.09 - $1.12
52-week range:
$0.85 - $4.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.34x
Volume:
5K
Avg. volume:
25.2K
1-year change:
-8.02%
Market cap:
$27.6M
Revenue:
--
EPS (TTM):
-$2.75
Earnings Data
Next earnings date for AKTX
Apr 15
2025
Most recent earnings per share
-$0.24
Missed by $0.24
(Sep 30/2024)
Consensus Estimate
--
(Sep 30/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
AKTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2024 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/19/2024 | Q2 | -- | -- | -$0.80 | -- | -- |
| 05/16/2024 | Q1 | -- | -- | -$0.83 | -- | -- |
| 12/31/2023 | Q4 | -- | -- | -$0.88 | -- | -- |
| 09/30/2023 | Q3 | -- | -- | -$0.57 | -- | -- |
| 09/27/2023 | Q2 | -- | -- | -$0.79 | -$1.00 | $0.21 |
| 05/16/2023 | Q1 | -- | -- | $0.26 | -$1.20 | $1.46 |
| 12/31/2022 | Q4 | -- | -- | -- | -$1.40 | -- |
| 09/30/2022 | Q3 | -- | -- | -- | -$0.80 | -- |
| 09/27/2022 | Q2 | -- | -- | -$1.91 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$1.93 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$2.49 | -- | -- |
| 12/03/2021 | Q3 | -- | -- | -$0.62 | -- | -- |
| 09/22/2021 | Q2 | -- | -- | -$2.26 | -- | -- |
| 06/29/2021 | Q1 | -- | -- | -$3.04 | -- | -- |
| 03/31/2021 | Q4 | -- | -- | -$13.84 | -- | -- |
| 12/11/2020 | Q3 | -- | -- | $0.54 | -- | -- |
| 09/01/2020 | Q2 | -- | -- | -$4.96 | -- | -- |
| 05/29/2020 | Q1 | -- | -- | -$2.98 | -- | -- |
| 03/16/2020 | Q4 | -- | -- | -$7.30 | -- | -- |
| 11/04/2019 | Q3 | -- | -- | -$2.60 | -- | -- |
| 08/29/2019 | Q2 | -- | -- | -$5.12 | -- | -- |
| 04/23/2019 | Q1 | -- | -- | -$3.22 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$4.44 | -- | -- |
| 11/15/2018 | Q3 | -- | -- | -$4.70 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$20.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | -$1.75 | -- | -- |
| 03/21/2018 | Q4 | -- | -- | -$20.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$20.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$0.54 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$20.00 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$20.00 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.71 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$20.00 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$5.07 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $40.00 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$120.00 | -- | -- |
| 06/30/2015 | Q2 | -- | -- | -$4.00 | -- | -- |
Akari Therapeutics PLC Earnings Questions
-
How Much did Akari Therapeutics PLC Generate in Revenue Last Quarter?
Akari Therapeutics PLC reported -- worth of top line sales in its most recent quarter.
-
Did Akari Therapeutics PLC Beat Earnings Last Quarter?
Akari Therapeutics PLC announced earnings per share of -$0.24 which represents a miss of analyst forecast a -- per share.
-
Is Akari Therapeutics PLC Profitable?
Akari Therapeutics PLC reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Akari Therapeutics PLC EPS Next Year?
Akari Therapeutics PLC's earnings are forecast to decrease from -$2.04 per share to -- per share next year representing a decrease of -29.64%.
-
When is Akari Therapeutics PLC's Earnings Date?
Currently, Akari Therapeutics PLC has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on July 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Did the Market Bottom Already?
The past few weeks have been among the most volatile…
Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
54
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Sell
47
RGC alert for Apr 15
Regencell Bioscience Holdings [RGC] is down 11.8% over the past day.
Sell
50
SLP alert for Apr 15
Simulations Plus [SLP] is up 4.69% over the past day.
Sell
46
ZLAB alert for Apr 15
Zai Lab [ZLAB] is up 6.77% over the past day.
